期刊
NANOMEDICINE
卷 13, 期 4, 页码 455-474出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2017-0242
关键词
cell culture models; cervical cancer; dicer substrate siRNA; E6 oncogene; human papillomavirus 16; RNA interference; siRNA; siRNA therapy
资金
- Canadian Institutes of Health Research (CIHR) [CPG 140188]
- Natural Sciences and Engineering Research Council of Canada (NSERC) [CHRP 478520-15]
- NSERC graduate student scholarships [PGS-D3: 460717-2014, CGS-D3: 454402-2014]
- Northern Ontario Heritage Fund Corporation (NOHFC)
High-risk human papillomaviruses infect skin and mucosa, causing approximately 5% of cancers worldwide. In the search for targeted nanotherapeutic approaches, siRNAs against the viral E6 transcript have been molecules of interest but have not yet seen successful translation into the clinic. By reviewing the past approximately 15 years of in vitro literature, we identify the need for siRNA validation protocols which concurrently evaluate ranges of key treatment parameters as well as characterize downstream process restoration in a methodical, quantitative manner and demonstrate their implementation using our own data. We also reflect on the future need for more appropriate cell culture models to represent patient lesions as well as the application of personalized approaches to identify optimal treatment strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据